Rare diseases
Investigational molecules
Locations
Calle Villarroel 170, 08036 Barcelona, Spain
Hospital Clinic De Barcelona in Barcelona, Spain specialises in clinical trials of conditions such as Non-small cell lung cancer, Plasma cell myeloma, Breast cancer, Hormone receptor positive HER2 negative breast cancer, and other specialisations. This site conducts important research.
At Hospital Clinic De Barcelona the Retina department concentrates on eye diseases including diabetic macular edema, diabetic retinopathy and macular edema secondary to retinal vein occlusion, with trials designed to test innovative injection therapies and novel delivery approaches to preserve or improve visual acuity.
These studies aim to enhance treatment effectiveness and safety for patients facing vision‑threatening conditions, supporting the site’s commitment to advancing retinal care.
In addition to ocular work, the centre conducts research on respiratory tract diseases, specifically bronchiectasis complicated by chronic Pseudomonas aeruginosa infection, evaluating new antibody therapies to reduce bacterial burden and improve lung function.
The goal is to provide more effective options for patients with persistent airway infections, ultimately aiming to enhance quality of life and respiratory health.
Clinical trials currently enrolling participants at this site.
Phase 3 Study of Pitolisant for Excessive Daytime Sleepiness in Narcolepsy Patients
SpainRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
SpainEfficacy and Safety of ALKS 2680 and Alixorexton in Adults with Narcolepsy Type 1
SpainPhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
SpainPhase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2
SpainPhase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
SpainEvaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus
SpainA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
SpainA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
SpainA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
SpainLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
SpainA Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
SpainMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
